TC
Insider
Terrance P. Coyne
EVP & CFOTerrance P. Coyne (EVP & CFO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales, 1 filed past the two-business-day deadline), most often in Royalty Pharma plc (RPRX). The largest single filing was $10.3M of RPRX (242,454 sh across 5 lots, as filed), executed Feb 2.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
14
0 buys · 14 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$38.4M
shares × price, as filed
Last traded
Aug 13
Filed Aug 17
Median ADV $206.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $38.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
14 filings
Sector per market data · by filing · past 12 months
Most traded names
RPRXRecent filings
RPRXSALE
Royalty Pharma plc
View filing →
$2.7M69,582 sh across 2 lots
Exec Jan 20
Filed Jan 23 · 5:30 PM ET † RPRXSALE Royalty Pharma plc View filing → $2.7M
69,582 sh across 2 lots
Exec Jan 2
Filed Jan 6 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $2.7M
69,582 sh across 2 lots
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $2.8M
69,582 sh across 2 lots
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $2.7M
68,958 sh across 3 lots
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $2.7M
69,594 sh across 2 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET